Skip to content

Pituitary hormone profile after Brain Injury

Pituitary Function Assessment after Traumatic Brain Injury in Children: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/07/044009
Enrollment
115
Registered
2022-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S069- Unspecified intracranial injury

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 3 month to 16 years 2. Hospitalized for a clinical indication like altered sensorium, seizures, amnesia, repeated vomiting, bleeding nose or Ear, skull fracture, or neurological signs after traumatic brain injury

Exclusion criteria

Exclusion criteria: 1. Patients who succumb within first 48 hours of hospitalization 2. Patients with pre-existing endocrinal disorder unrelated to existing illness 3. Patients with previously diagnosed static or progressive central nervous system disease (like epilepsy, brain tumor, meningoencephalitis, cerebral palsy) 4. Patients with history of consumption of drugs in the last 12 months which can affect interpretation of pituitary hormone levels (example corticosteroids, anti-epileptic drugs) 5. Patients with any major congenital anomalies (example neural tube defects) or chromosomal disorders 6. Patients who discontinue treatment before discharge

Design outcomes

Primary

MeasureTime frame
Incidence of pituitary disorders in children with traumatic brain injuryTimepoint: Baseline, 6 months, 12 months, 24 months

Secondary

MeasureTime frame
a. Association of pituitary dysfunction with the injury characteristics (severity, type, mechanism) b. Association of pituitary dysfunction with neuronal injury biomarkers c. Resolution of pituitary dysfunction in diagnosed cases during the study period Timepoint: 6, 12 and 24 months

Countries

India

Contacts

Public ContactAashima Dabas

Maulana Azad Medical College

dr.aashimagupta@gmail.com9968604424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026